Baxion
Screening
Tags
Alerts
Theme
Mereo Biopharma Group PLC
MREO
·
NASDAQ
·
$0.33
Share Price as of 11/2
·
$53M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/11/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/19/26
10-Q
Q3 ended 09/30/25
11/10/25
10-Q
Q2 ended 06/30/25
08/12/25
Disclosures
Filter
8-K
Current report
08/19/26
8-K
Current report
08/11/26
8-K
Current report
08/11/26
8-K
Current report
05/14/26
8-K
Current report
05/12/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
02/02/26
S-8
Registration of securities for employees
01/23/25
424B3
Prospectus
12/04/24
S-3
Shelf registration
11/25/24
424B5
Prospectus supplement
06/14/24
Proxies
Filter
DEF 14A
Definitive proxy
04/09/26
PRE 14A
Preliminary proxy
03/27/26
DEF 14A
Definitive proxy
04/08/25
DEF 14A
Definitive proxy
04/24/24
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/28/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
05/15/26
SC 13G
Beneficial ownership
05/14/26
Form 4
Insider transaction
02/27/26
Other
Filter
ARS
Annual report to shareholders
04/09/26
ARS
Annual report to shareholders
04/08/25
EFFECT
Request for effectiveness
12/04/24
CORRESP
Correspondence with the SEC
12/03/24
UPLOAD
Letter from the SEC
12/02/24
Latest Filings
Filter
8-K
Current report
08/19/26
10-Q
Q2 ended 06/30/26
08/11/26
8-K
Current report
08/11/26
8-K
Current report
08/11/26
8-K
Current report
05/14/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/28/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
05/15/26
SC 13G
Beneficial ownership
05/14/26
Form 4
Insider transaction
02/27/26